Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06909500 · ClinicalTrials.gov registry record · NA
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,178
- Enrollment target
NCT06909500 is a NA study that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 1,178 participants.
The verdict
NCT06909500, a NA study, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,178 participants
- Enrollment target
Study Summary
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
Interventions
- OTHER Survey Administration
- OTHER Text Message
- BEHAVIORAL Smartphone app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,178 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06909500
The ClinicalTrials.gov registry entry for NCT06909500 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT06909500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06909500 about?
NCT06909500 is a clinical study titled "A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users". This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of ...
What is the current status of trial NCT06909500?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,178 participants. The study started on 2026-07-15. Estimated completion is 2027-11-15.
What interventions are being tested in trial NCT06909500?
The interventions under investigation include: Survey Administration (OTHER), Text Message (OTHER), Smartphone app (BEHAVIORAL).
Who is sponsoring clinical trial NCT06909500?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.